QDIS Blog

Informex Meeting in San Francisco

by Ed Vawter @ 3:48 pm. Filed under Asides

Just wanted to let you know that I am going to be at the Informex conference at the Moscone Convention Center in San Francisco Feb 13-16. If anyone else is going to be there and would like to meet up, send me an email and we’ll see about getting together.

For those of you not familiar with Informex it is a big meeting of pharmaceutical contract manufacturers and fine chemicals producers. The big attraction is the networking and ability to meet with a lot of companies in a few days. I go every year to meet with contract manufacturers and see what has changed and who has added new capabilities. it also gives me a chance to catch up with many of my friends in the industry.

Hope to see some folks there!

Technorati Tags: Informex

Email Ed Vawter

Sanofi Antibiotic Ketek Said Safe By The FDA

Outsourcing animal testing

I’m Attending Podcast Expo

FDA panel to vote on America’s first bird flu vaccine

FDA Wants Additional Information on Indiplon

[

Print This Post ] [Email it!] [Comments (0)] [Permalink] [Trackback]

Cardinal Health to Sell Pharmaceutical Services

by Ed Vawter @ 12:50 pm. Filed under Pharma News

Another major deal. Cardinal Health, who I have done work with in the past, is selling their pharmaceutical services division to the private investment group The Blackstone Group for $3.3 billion!

PharmaLive: Cardinal Health to Sell Pharmaceutical Technologies and Services Segment to The Blackstone Group for $3.3 Billion

What is interesting is that this process took less than two months to put together!! That it extremely quick given the scale of the sale.

This is interesting and Cardinal says it will allow them to focus on their core services to hospitals and pharmacies. You may remember that Cardinal was responsible for freezing 500,000 doses of flu vaccine and thus making them useless back in October that were made by Novartis. Cardinal Health is also one of the announced manufacturer of Tamiflu for Roche.

I think the price in this case may be about right sine the unit has $1.8 billion in annual revenue. However t is hard to factor in the intangibles such as the failure to portly handle the flu vaccine and a class 1 recall of electronic infusion pumps in Aug of last year.

Other Resources
Cardinal Health to Sell Pharmaceutical Technologies to Blackstone (Cardinal Health press release).

Technorati Tags: Cardinal Health, pharmaceutical deals, Blackstone group